Phase I Study of West Nile Virus Vaccine

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 3, 2006

Study Completion Date

December 28, 2007

Conditions

West Nile Fever

Interventions

DRUG

VRC-WNVDNA020-00-VP

Trial Locations (1)

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00300417 - Phase I Study of West Nile Virus Vaccine | Biotech Hunter | Biotech Hunter